723 related articles for article (PubMed ID: 16093455)
21. Genetic conversion of an SMN2 gene to SMN1: a novel approach to the treatment of spinal muscular atrophy.
DiMatteo D; Callahan S; Kmiec EB
Exp Cell Res; 2008 Feb; 314(4):878-86. PubMed ID: 18078930
[TBL] [Abstract][Full Text] [Related]
22. Genetic testing and risk assessment for spinal muscular atrophy (SMA).
Ogino S; Wilson RB
Hum Genet; 2002 Dec; 111(6):477-500. PubMed ID: 12436240
[TBL] [Abstract][Full Text] [Related]
23. Survival motor neuron SMN1 and SMN2 gene promoters: identical sequences and differential expression in neurons and non-neuronal cells.
Boda B; Mas C; Giudicelli C; Nepote V; Guimiot F; Levacher B; Zvara A; Santha M; LeGall I; Simonneau M
Eur J Hum Genet; 2004 Sep; 12(9):729-37. PubMed ID: 15162126
[TBL] [Abstract][Full Text] [Related]
24. Therapeutics development for spinal muscular atrophy.
Sumner CJ
NeuroRx; 2006 Apr; 3(2):235-45. PubMed ID: 16554261
[TBL] [Abstract][Full Text] [Related]
25. Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease.
Monani UR
Neuron; 2005 Dec; 48(6):885-96. PubMed ID: 16364894
[TBL] [Abstract][Full Text] [Related]
26. [Molecular basis of spinal muscular atrophy: th SMN gene].
Tizzano E; Baiget M
Neurologia; 2000 Nov; 15(9):393-400. PubMed ID: 11195146
[TBL] [Abstract][Full Text] [Related]
27. Spinal muscular atrophy: from gene to therapy.
Wirth B; Brichta L; Hahnen E
Semin Pediatr Neurol; 2006 Jun; 13(2):121-31. PubMed ID: 17027862
[TBL] [Abstract][Full Text] [Related]
28. A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels.
Wolstencroft EC; Mattis V; Bajer AA; Young PJ; Lorson CL
Hum Mol Genet; 2005 May; 14(9):1199-210. PubMed ID: 15790598
[TBL] [Abstract][Full Text] [Related]
29. Spinal muscular atrophy: molecular genetics and diagnostics.
Ogino S; Wilson RB
Expert Rev Mol Diagn; 2004 Jan; 4(1):15-29. PubMed ID: 14711346
[TBL] [Abstract][Full Text] [Related]
30. Population screening and cascade testing for carriers of SMA.
Smith M; Calabro V; Chong B; Gardiner N; Cowie S; du Sart D
Eur J Hum Genet; 2007 Jul; 15(7):759-66. PubMed ID: 17392705
[TBL] [Abstract][Full Text] [Related]
31. Implementation of SMA carrier testing in genetic laboratories: comparison of two methods for quantifying the SMN1 gene.
Cuscó I; Barceló MJ; Baiget M; Tizzano EF
Hum Mutat; 2002 Dec; 20(6):452-9. PubMed ID: 12442269
[TBL] [Abstract][Full Text] [Related]
32. Molecular mechanisms of spinal muscular atrophy.
Sumner CJ
J Child Neurol; 2007 Aug; 22(8):979-89. PubMed ID: 17761653
[TBL] [Abstract][Full Text] [Related]
33. Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector.
Baughan T; Shababi M; Coady TH; Dickson AM; Tullis GE; Lorson CL
Mol Ther; 2006 Jul; 14(1):54-62. PubMed ID: 16580882
[TBL] [Abstract][Full Text] [Related]
34. Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy.
Jarecki J; Chen X; Bernardino A; Coovert DD; Whitney M; Burghes A; Stack J; Pollok BA
Hum Mol Genet; 2005 Jul; 14(14):2003-18. PubMed ID: 15944201
[TBL] [Abstract][Full Text] [Related]
35. Spinal muscular atrophy: state-of-the-art and therapeutic perspectives.
Wirth B
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Jun; 3(2):87-95. PubMed ID: 12215230
[TBL] [Abstract][Full Text] [Related]
36. Correlation of SMNt and SMNc gene copy number with age of onset and survival in spinal muscular atrophy.
Taylor JE; Thomas NH; Lewis CM; Abbs SJ; Rodrigues NR; Davies KE; Mathew CG
Eur J Hum Genet; 1998; 6(5):467-74. PubMed ID: 9801871
[TBL] [Abstract][Full Text] [Related]
37. Molecular analysis of SMA patients without homozygous SMN1 deletions using a new strategy for identification of SMN1 subtle mutations.
Clermont O; Burlet P; Benit P; Chanterau D; Saugier-Veber P; Munnich A; Cusin V
Hum Mutat; 2004 Nov; 24(5):417-27. PubMed ID: 15459957
[TBL] [Abstract][Full Text] [Related]
38. Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells.
Angelozzi C; Borgo F; Tiziano FD; Martella A; Neri G; Brahe C
J Med Genet; 2008 Jan; 45(1):29-31. PubMed ID: 17932121
[TBL] [Abstract][Full Text] [Related]
39. Identification of a battery of tests for drug candidate evaluation in the SMNDelta7 neonate model of spinal muscular atrophy.
El-Khodor BF; Edgar N; Chen A; Winberg ML; Joyce C; Brunner D; Suárez-Fariñas M; Heyes MP
Exp Neurol; 2008 Jul; 212(1):29-43. PubMed ID: 18455159
[TBL] [Abstract][Full Text] [Related]
40. Spinal muscular atrophy carrier screening by multiplex polymerase chain reaction using dried blood spot on filter paper.
Majumdar R; Rehana Z; Al Jumah M; Fetaini N
Ann Hum Genet; 2005 Mar; 69(Pt 2):216-21. PubMed ID: 15720302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
